Chronic Stable Angina
Depression and CV diseases: cardiologist perspectives
LANDMARK TRIALS IN STABLE CAD
Chronic Total Occlusions: The Road Less Traveled
Courage TRIAL 2007
Metabolic syndrome is a key determinant of microvascular function
The Impact of Different Treatment Strategies on Cardiac Death and MI Rates in Patients with Type 2 Diabetes and Stable Coronary Disease: A Report from.
ESC Congress 2009 Clinical Trial Summary Slides. AAA Primary outcome (coronary event, stroke, revascularization) similar in aspirin and placebo arms (HR.
Aggressive Lipid Lowering Treatment
Prognostic Value of B-Type Natriuretic Peptides in Patients with Stable Coronary Artery Disease
Appropriateness of Percutaneous Coronary Interventions in Washington State
Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention
